Gain clarity in the face of complexity:
  • Prioritize the markets that provide the most favorable conditions for commercialization
  • Incorporate expert insight into your most critical market access decisions—and your everyday workflow
  • Calibrate your strategic assumptions before committing resources with comprehensive, country-specific analysis
Schedule a Demo / Ask Us a Question
Enjoy Access to:
  • Top-Level Epidemiology, Mortality, and Global Burden of Disease Data
  • Therapy Area Specific Tools and Analytics
  • Market Statistics Across the Globe
Explore the Insights Library:
  • Commercialization Outlooks
  • Pricing and Reimbursement Process Flowcharts
  • Webinars
  • Challenges and Opportunities
HTA Decision Outcomes
10 oncology indications in
14 countries/21 agencies
Additional Therapeutic Areas
Coming in 2015, including
Metabolic, Immune, and
Cardiovascular
Commercial Attractiveness Focus
A first-of-its-kind “Target Your Market”
tool with customizable thresholds for
40+ KPIs across ~150 countries
Expanded Geographic Focus
In-depth analysis
of 29 Countries

Country-specific Drivers
of Commercial Success
Country Archetypes
Leverage Payer Value Messaging
in Multiple Countries

A Guided Tour of
Global Market Access
Request a Demo / Ask us a Question
Decision Resources Group brands include: